199 related articles for article (PubMed ID: 19104056)
21. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.
Cherlyn SY; Woon PS; Liu JJ; Ong WY; Tsai GC; Sim K
Neurosci Biobehav Rev; 2010 May; 34(6):958-77. PubMed ID: 20060416
[TBL] [Abstract][Full Text] [Related]
22. Location matters: distinct DNA methylation patterns in GABAergic interneuronal populations from separate microcircuits within the human hippocampus.
Ruzicka WB; Subburaju S; Coyle JT; Benes FM
Hum Mol Genet; 2018 Jan; 27(2):254-265. PubMed ID: 29106556
[TBL] [Abstract][Full Text] [Related]
23. Building models for postmortem abnormalities in hippocampus of schizophrenics.
Benes FM
Schizophr Res; 2015 Sep; 167(1-3):73-83. PubMed ID: 25749020
[TBL] [Abstract][Full Text] [Related]
24. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs.
Eastwood SL; Harrison PJ
Mol Psychiatry; 2000 Jul; 5(4):425-32. PubMed ID: 10889554
[TBL] [Abstract][Full Text] [Related]
25. Regional differences in GABAergic modulation for TEA-induced synaptic plasticity in rat hippocampal CA1, CA3 and dentate gyrus.
Suzuki E; Okada T
Neurosci Res; 2007 Oct; 59(2):183-90. PubMed ID: 17669533
[TBL] [Abstract][Full Text] [Related]
26. Amygdalocortical circuitry in schizophrenia: from circuits to molecules.
Benes FM
Neuropsychopharmacology; 2010 Jan; 35(1):239-57. PubMed ID: 19727065
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
Guidotti A; Auta J; Chen Y; Davis JM; Dong E; Gavin DP; Grayson DR; Matrisciano F; Pinna G; Satta R; Sharma RP; Tremolizzo L; Tueting P
Neuropharmacology; 2011 Jun; 60(7-8):1007-16. PubMed ID: 21074545
[TBL] [Abstract][Full Text] [Related]
28. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression.
Fatemi SH; Earle JA; McMenomy T
Mol Psychiatry; 2000 Nov; 5(6):654-63, 571. PubMed ID: 11126396
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder.
Veldic M; Kadriu B; Maloku E; Agis-Balboa RC; Guidotti A; Davis JM; Costa E
Schizophr Res; 2007 Mar; 91(1-3):51-61. PubMed ID: 17270400
[TBL] [Abstract][Full Text] [Related]
30. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
Neurosci Res; 2004 Sep; 50(1):77-84. PubMed ID: 15288501
[TBL] [Abstract][Full Text] [Related]
32. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.
Law AJ; Deakin JF
Neuroreport; 2001 Sep; 12(13):2971-4. PubMed ID: 11588613
[TBL] [Abstract][Full Text] [Related]
33. Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms.
Benes FM
Schizophr Bull; 2007 Jul; 33(4):932-6. PubMed ID: 17575303
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of GABA and glutamate-receptor subunits and enzymes involved in GABA metabolism between electrophysiologically identified hippocampal CA1 pyramidal cells and interneurons.
Telfeian AE; Tseng HC; Baybis M; Crino PB; Dichter MA
Epilepsia; 2003 Feb; 44(2):143-9. PubMed ID: 12558566
[TBL] [Abstract][Full Text] [Related]
35. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian S; Kim JJ; Potkin SG; Hagman JO; Tafazzoli A; Bunney WE; Jones EG
Arch Gen Psychiatry; 1995 Apr; 52(4):258-66. PubMed ID: 7702443
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: a postmortem morphometric study.
Kolomeets NS; Orlovskaya DD; Rachmanova VI; Uranova NA
Synapse; 2005 Jul; 57(1):47-55. PubMed ID: 15858835
[TBL] [Abstract][Full Text] [Related]
37. Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.
McCullumsmith RE; Kristiansen LV; Beneyto M; Scarr E; Dean B; Meador-Woodruff JH
Brain Res; 2007 Jan; 1127(1):108-18. PubMed ID: 17113057
[TBL] [Abstract][Full Text] [Related]
38. Microendophenotypes of psychiatric disorders: phenotypes of psychiatric disorders at the level of molecular dynamics, synapses, neurons, and neural circuits.
Kida S; Kato T
Curr Mol Med; 2015; 15(2):111-8. PubMed ID: 25732153
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
[TBL] [Abstract][Full Text] [Related]
40. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.
Chambers JS; Perrone-Bizzozero NI
Neurochem Res; 2004 Dec; 29(12):2293-302. PubMed ID: 15672553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
